Dong Huixi, Yang Mei, Liu Liang, Zhang Chenxi, Liu Mengqi, Shen Yidong, Liu Huanzhong, Hao Wei
Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital, Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health, Changsha, Hunan, 410011, China.
Shenzhen Kangning Hospital, Shenzhen, Guangzhou, 518020, China.
BMC Psychiatry. 2017 May 12;17(1):183. doi: 10.1186/s12888-017-1346-7.
There is little research of psychiatric comorbidity differences among people with different types of drug dependence in Chinese population. We explored demographic and comorbid psychiatric differences among methamphetamine- dependent males (MDs), heroin-dependent males (HDs) and methamphetamine and heroin co-dependent males (M/HDs) in Hunan province, China.
A cross-sectional, structured and clinical interview method was used to examine differences in DSM-IV-TR Axis I Disorders among 346 MDs, 698 HDs and 247 M/HDs from three compulsory rehabilitation centers and two voluntary rehabilitation centers in Hunan.
MDs and M/HDs were younger, more likely to choose inhalation administration, less likely to have a family history of substance use, less likely to have undergone detoxification treatment, had higher incomes and shorter duration of drug use than HDs. Overall, methamphetamine-dependence related to higher rates of current and lifetime psychotic disorders, lifetime hallucinogen use disorders. Heroin-dependence related to higher rates of current and lifetime substance-induced mood disorders, sedative/hypnotic/anxiolytic and other drug use disorders and current alcohol use disorder. For M/HDs, they were more likely to have any other lifetime substance use disorders than MDs and HDs.
There were substantial differences in epidemiological characteristics and comorbidity among MD, HD and M/HD groups, which highlights the urgent need to develop treatment services and policies for drug-specific users in China.
在中国人群中,针对不同类型药物依赖者的精神疾病共病差异的研究较少。我们探讨了中国湖南省甲基苯丙胺依赖男性(MDs)、海洛因依赖男性(HDs)以及甲基苯丙胺和海洛因共同依赖男性(M/HDs)在人口统计学和共病精神疾病方面的差异。
采用横断面、结构化临床访谈方法,对来自湖南省三个强制戒毒所和两个自愿戒毒所的346名MDs、698名HDs和247名M/HDs进行DSM-IV-TR轴I障碍差异检查。
与HDs相比,MDs和M/HDs年龄更小,更倾向于选择吸入给药方式,有物质使用家族史的可能性更小,接受戒毒治疗的可能性更小,收入更高且吸毒时间更短。总体而言,甲基苯丙胺依赖与当前及终生精神病性障碍、终生致幻剂使用障碍的发生率较高相关。海洛因依赖与当前及终生物质所致心境障碍、镇静催眠药/抗焦虑药及其他药物使用障碍以及当前酒精使用障碍的发生率较高相关。对于M/HDs,他们比MDs和HDs更有可能患有任何其他终生物质使用障碍。
MD、HD和M/HD组在流行病学特征和共病方面存在显著差异,这凸显了中国迫切需要为特定药物使用者制定治疗服务和政策。